搜索结果

疾病ID:TCMBANKDI003835

疾病名:Hemochromatosis

MeSH_Name:Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases

HPO_Name:-

UMLS_Name:Disease or Syndrome

DO_Name:disease of metabolism; genetic disease

疾病类型:disease

DisGeNET_Link:C0018995

MeSH_Link:C16; C18

HPO_Link:-

UMLS_Link:T047

DO_Link:DOID:0014667; DOID:630

HERB_ID:-

   疾病对应的植物
ID 拉丁名 药名 药用植物名 功能与主治 来源 药用部位 使用民族
   疾病对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN058205 trans-resveratrol (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; SRT501; AX8004672; DB02709; RP17549; NCGC00017352-05; NCGC00017352-13; NCGC00017352-19; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 4CN-0696; I06-0437; 3,4',5-Trihydroxy-trans-stilbene; (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; s1396; HMS1990H15; SAM001246888; CPD000058206; CU-01000001503-3; BPBio1_000479; NCGC00024003-14; (E)-5-(p-Hydroxystyryl)resorcinol; FT-0082623; Tox21_501111; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 01R360; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Tox21_303376; MLS001055357; NCGC00024003-13; GP5884; A827984; resveratrol; NCGC00017352-09; NCGC00017352-15; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; NCGC00024003-11; D0U3EP; ACN-034773; ST057251; EU-0101111; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; HY-16561; N1848; ACT09778; NCGC00017352-17; BRD-K80738081-001-09-6; KUC104385N; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; STL; MLS001424228; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; HMS1569F17; Resveratrol, Vetec(TM) reagent grade, 98%; HMS1921N04; IDI1_002152; Resvida; KB-02515; SR-01000000163-10; NCGC00017352-08; AB00052942_31; 3,5,4'-Trihydroxystilbene; trans-Stilbene-3,4',5-triol; Tox21_110257; NCGC00024003-12; trans-3,4′,5-Trihydroxystilbene; trans-3,4',5 - trihydroxystilbene; ZB000650; ZINC6787; DSSTox_RID_78898; NCGC00024003-09; 3fts; BB_NC-2570; SRT-501; ZX-AS004941; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; BRD-K80738081-001-23-7; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; NSC327430; LS-2146; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; NCGC00024003-04; DSSTox_CID_11980; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Prestwick3_000508; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; Resveratrol, European Pharmacopoeia (EP) Reference Standard; NCGC00015894-02; ARONIS24568; STL146386; R 5010; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; AC1L9HIC; BSPBio_003461; REGID_for_CID_445154; C14H12O3; SR-01000000163-11; 501-36-0; C03582; SRT 501; NSC 327430; NSC-327430; Spectrum5_000552; AS-12413; Trans-3,4′ NCGC00024003-06; AKOS005720936; BG01529320; BBC/741; HMS1792H15; NCGC00258925-01; TL8003323; AB00052942-29; SR-01000000163-4; SR-01000000163-16; BSPBio_000435; Opera_ID_586; NC00349; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; ZX-AT013797; 375823-41-9; HMS3403H15; 3,4',5-Trihydroxystilbene; HMS2232A18; KSC-10-164; AN-865; LMPK13090005; AJ-08292; OR46018; R0071; CHEMBL165; BRD-K25591257-001-01-2; Resveratrol, E-; BBL028252; NCGC00024003-05; LP01111; UNII-Q369O8926L; CCG-38874; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MFCD00133799; 2l98; BDBM23926; SGCUT00007; GP2549; Resveratrol, trans-; CC-34242; ST2408097; MLS001076538; AK-39118; HMS1362H15; NCGC00024003-07; ABP000376; SBB055452; NCGC00017352-16; trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; Tox21_110257_1; BRD-K80738081-001-06-2; Resveratrol, certified reference material, TraceCERT(R); 3,4',5-Stilbenetriol; MCULE-5678456463; J10118; BSPBio_001114; HMS2052I09; Resveratrol, >=99% (HPLC); CS-1050; SCHEMBL19425; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; Resveratol; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; HMS3263O04; 4jaz; AB0006623; CAS-501-36-0; CCRIS 8952; MLS000069735; trans-3,4',5-trihydroxystilbene; 4qer; Tox21_201374; to_000079; SPECTRUM1502223; BC202036; API0000480; NCGC00017352-10; CHEBI:27881; NCGC00017352-24; SY014849; 3,4',5-trihydroxy-stilbene; NCGC00017352-06; PREVENTION 8 (RESVERATROL); MolPort-002-499-801; (E)-resveratrol; BCPP000091; Prestwick_619; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; SMR000058206; cid_445154; Q369O8926L; Resveratrol, analytical standard; DSSTox_GSID_31980; NCGC00017352-11; AC-727; HMS2096F17; BS0159; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; BRD-K80738081-001-10-4; NCGC00017352-12; MLS002222231; Resveratrol, natural; Lopac0_001111; BR-39118; CJ-00111; NCGC00017352-07; DTXSID4031980; CR-003; Stilbene, 2f; NCGC00017352-18; NCGC00024003-10; SC-11924; SR-01000000163-3; MLS002207121; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; NCGC00024003-00; HMS3649A20; KS-5047; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; NCGC00017352-14; HSDB 7571; NCGC00024003-08; 533C1DA0-4104-42B5-9D32-9265F40857E4; RM-1812; REGID_for_CID_6240; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; BIK9013; NCGC00257465-01; GTPL8741; BG00606847; NCGC00261796-01; CHEBI:45713; SR-01000000163; Resveratrol, synthetic; SR-01000000163-9; Prestwick2_000508; N88795; 3,5,4'-Trihydroxy-trans-stilbene; resveratrol; 1,3-Benzenediol, 5-((1Z)-2-(4-hydroxyphenyl)ethenyl)-; cis-3,5,4'-trihydroxystilbene; AIDS025474; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; SPBio_002356; BPBio1_000479; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Spectrum4_001896; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; EU-0101111; ST057251; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; resveratrol ; KBioSS_000454; 1684AH; Spectrum3_001821; STL; CHEBI:36002; SPBio_001513; IDI1_002152; Prestwick1_000508; 05F9DB2A-D7E6-4063-8E5B-F7842CF74A5E; 3,5,4'-Trihydroxystilbene; 3,4',5-trihydroxy stilbene; (Z)-resveratrol; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; trans-3,4′,5-Trihydroxystilbene; 31100-06-8; 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Cis resveratrol; SRT-501; NSC327430; 3,4′,5-Trihydroxy-trans-stilbene; Spectrum_001148; 5-[(1Z)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00024003-04; Prestwick3_000508; NCGC00015894-02; Z-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; NCGC00017352-03; SCHEMBL1931746; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; BSPBio_003461; Bio2_000877; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1-; 31100-06-8 (DELETED); Z-Resveratrol; UNII-AUA0K06FSB; 501-36-0; C03582; AKOS025395422; KBio2_004196; KBio3_002965; Prestwick0_000508; NSC 327430; 34092_RIEDEL; KBio3_000848; NCGC00017352-02; Spectrum5_000552; MolPort-003-850-143; NCGC00024003-06; KBio2_005590; SpecPlus_000391; AC1LU7HY; AUA0K06FSB; KBioGR_000454; AIDS-025474; BSPBio_000435; cis-resveratrol; KBio2_006764; KBio2_001628; KBioGR_002457; CHEMBL87333; 3,4',5-Trihydroxystilbene; Lopac-R-5010; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; KBio2_000454; Resveratrol, (Z)-; SGCUT00007; CJ-13797; NCGC00024003-07; Resveratrol (Z)-form [MI]; NCGC00017352-01; I14-7425; DivK1c_006487; MolMap_000045; 3,4',5-Stilbenetriol; Oprea1_727238; Tocris-1418; DB-072954; NCGC00017352-04; BSPBio_001114; BDBM50131698; 434C671; LUKBXSAWLPMMSZ-UPHRSURJSA-; KBio3_000847; CAS-501-36-0; SMP1_000257; 4q93; MLS000069735; cis-5-[2-(4-Hydroxyphenyl)ethenyl]benzene-1,3-diol; ZINC00006787; (Z)-3,5,4'-trihydroxystilbene; to_000079; SPECTRUM1502223; trans-Resveratrol; R5010_SIGMA; KBio2_003022; 61434-67-1; NCGC00024003-02; NCGC00015894-01; CHEBI:27881; Resveratrol; AC-24235; (E)-resveratrol; Prestwick_619; 5-[2-(4-hydroxyphenyl)vinyl]resorcinol; SMR000058206; TNP00294; Resveratrol, Z-; ZINC12353732; Lopac0_001111; cis-3,4',5-trihydroxystilbene; NCI60_002840; 5-[(E)-2-(4-hydroxyphenyl)vinyl]resorcinol; Bio2_000397; NCGC00024003-00; (Z)-3,4',5-trihydroxystilbene; 3,5-Dihydroxy-4'-methoxystilbene; 3, 5,4'-trihydroxy-trans-stilbene; cis-3,4,5-Trihydroxystilbene; NCGC00024003-08; RM-1812; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; SDCCGMLS-0002998.P003; KBioSS_001628; KBio1_001431; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEBI:45713; Spectrum2_001497; Prestwick2_000508; 3,5,4'-Trihydroxy-trans-stilbene C14H12O3 228.24 g/mol C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O
   疾病对应的靶点
靶点ID 基因名 基因别名 描述
TCMBANKGE003321 F5 FVL; PCCF; RPRGL1; THPH2 coagulation factor V
TCMBANKGE014672 FTH1 FHC; FTH; FTHL6; HFE5; PIG15; PLIF ferritin heavy chain 1
TCMBANKGE004071 IREB2 ACO3; IRE-BP 2; IRE-BP2; IRP2; IRP2AD; NDCAMA iron responsive element binding protein 2
TCMBANKGE001522 ALAS2 ALAS-E; ALASE; ANH1; ASB; SIDBA1; XLDPP; XLEPP; XLSA 5'-aminolevulinate synthase 2
TCMBANKGE000452 CFTR ABC35; ABCC7; CF; CFTR/MRP; MRP7; TNR-CFTR; dJ760C5.1 CF transmembrane conductance regulator
TCMBANKGE000742 SMAD7 CRCS3; MADH7; MADH8 SMAD family member 7
TCMBANKGE015062 AKR1D1 3o5bred; CBAS2; SRD5B1 aldo-keto reductase family 1 member D1
TCMBANKGE012384 UBE2D1 E2(17)KB1; SFT; UBC4/5; UBCH5; UBCH5A ubiquitin conjugating enzyme E2 D1
TCMBANKGE001076 SOD2 GClnc1; IPO-B; IPOB; MNSOD; MVCD6; Mn-SOD superoxide dismutase 2
TCMBANKGE001103 MDM2 ACTFS; HDMX; LSKB; hdm2 MDM2 proto-oncogene
TCMBANKGE013621 SUCNR1 GPR91 succinate receptor 1
TCMBANKGE014782 SLC11A2 AHMIO1; DCT1; DMT1; NRAMP2 solute carrier family 11 member 2
TCMBANKGE007365 IGFALS ACLSD; ALS insulin like growth factor binding protein acid labile subunit
TCMBANKGE003730 HEPH CPL hephaestin
TCMBANKGE013682 GNPAT DAP-AT; DAPAT; DHAPAT; RCDP2 glyceronephosphate O-acyltransferase
TCMBANKGE006656 B2M IMD43 beta-2-microglobulin
TCMBANKGE000274 CCL2 GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF C-C motif chemokine ligand 2
TCMBANKGE004520 CYBRD1 CYB561A2; DCYTB; FRRS3 cytochrome b reductase 1
TCMBANKGE001963 UBL3 HCG-1; PNSC1 ubiquitin like 3
TCMBANKGE000230 ADIPOQ ACDC; ACRP30; ADIPQTL1; ADPN; APM-1; APM1; GBP28 adiponectin, C1Q and collagen domain containing
TCMBANKGE000134 EPO DBAL; ECYT5; EP; MVCD2 erythropoietin
TCMBANKGE000298 SOD1 ALS; ALS1; HEL-S-44; IPOA; SOD; STAHP; hSod1; homodimer superoxide dismutase 1
TCMBANKGE007109 TRIM31 C6orf13; HCG1; HCGI; RNF tripartite motif containing 31
TCMBANKGE000206 FOXC2 FKHL14; LD; MFH-1; MFH1 forkhead box C2
TCMBANKGE001665 PIEZO1 DHS; FAM38A; LMPH3; LMPHM6; Mib piezo type mechanosensitive ion channel component 1
TCMBANKGE011364 GDF15 GDF-15; MIC-1; MIC1; NAG-1; PDF; PLAB; PTGFB growth differentiation factor 15
TCMBANKGE013170 ELANE ELA2; GE; HLE; HNE; NE; PMN-E; SCN1 elastase, neutrophil expressed
TCMBANKGE006832 IGHG3 IgG3 immunoglobulin heavy constant gamma 3 (G3m marker)
TCMBANKGE000589 CD68 GP110; LAMP4; SCARD1 CD68 molecule
TCMBANKGE001069 MPO - myeloperoxidase
TCMBANKGE001037 MMP2 CLG4; CLG4A; MMP-2; MMP-II; MONA; TBE-1 matrix metallopeptidase 2
TCMBANKGE000271 APOE AD2; APO-E; ApoE4; LDLCQ5; LPG apolipoprotein E
TCMBANKGE013713 SHBG ABP; SBP; TEBG sex hormone binding globulin
TCMBANKGE001126 NFE2L2 HEBP1; IMDDHH; NRF2; Nrf-2 nuclear factor, erythroid 2 like 2
TCMBANKGE000479 TIMP1 CLGI; EPA; EPO; HCI; TIMP; TIMP-1 TIMP metallopeptidase inhibitor 1
TCMBANKGE013468 NMBR BB1; BB1R; NMB-R neuromedin B receptor
TCMBANKGE009398 SLC40A1 FPN1; HFE4; IREG1; MST079; MSTP079; MTP1; SLC11A3 solute carrier family 40 member 1
TCMBANKGE012841 HLA-A HLAA major histocompatibility complex, class I, A
TCMBANKGE007368 GSTP1 DFN7; FAEES3; GST3; GSTP; HEL-S-22; PI glutathione S-transferase pi 1
TCMBANKGE004562 CP CP-2 ceruloplasmin
TCMBANKGE005984 TFR2 HFE3; TFRC2 transferrin receptor 2
TCMBANKGE010087 TFRC CD71; IMD46; T9; TFR; TFR1; TR; TRFR; p90 transferrin receptor
TCMBANKGE000141 CALR CRT; HEL-S-99n; RO; SSA; cC1qR calreticulin
TCMBANKGE000574 GAST GAS gastrin
TCMBANKGE008692 UROD PCT; UPD uroporphyrinogen decarboxylase
TCMBANKGE014962 COX8A COX; COX8; COX8-2; COX8L; VIII; VIII-L cytochrome c oxidase subunit 8A
TCMBANKGE000889 HFE HFE1; HH; HLA-H; MVCD7; TFQTL2 homeostatic iron regulator
TCMBANKGE001547 ALDH2 ALDH-E2; ALDHI; ALDM aldehyde dehydrogenase 2 family member
TCMBANKGE006834 FTL LFTD; NBIA3 ferritin light chain
TCMBANKGE000428 SERPINA1 A1A; A1AT; AAT; PI; PI1; PRO2275; alpha1AT; nNIF serpin family A member 1
TCMBANKGE000823 GABPA E4TF1-60; E4TF1A; NFT2; NRF2; NRF2A; RCH04A07 GA binding protein transcription factor subunit alpha
TCMBANKGE012260 TF HEL-S-71p; PRO1557; PRO2086; TFQTL1 transferrin
TCMBANKGE001129 ARNTL BMAL1; BMAL1c; JAP3; MOP3; PASD3; TIC; bHLHe5 aryl hydrocarbon receptor nuclear translocator like
TCMBANKGE002568 ALAD ALADH; PBGS aminolevulinate dehydratase
TCMBANKGE004227 ACO1 ACONS; HEL60; IREB1; IREBP; IREBP1; IRP1 aconitase 1
TCMBANKGE005662 ALB HSA; PRO0883; PRO0903; PRO1341 albumin
TCMBANKGE009361 GPT AAT1; ALT1; GPT1 glutamic--pyruvic transaminase
TCMBANKGE007230 FXN CyaY; FA; FARR; FRDA; X25 frataxin
TCMBANKGE005318 S100A9 60B8AG; CAGB; CFAG; CGLB; L1AG; LIAG; MAC387; MIF; MRP14; NIF; P14 S100 calcium binding protein A9
TCMBANKGE000101 PGF D12S1900; PGFL; PIGF; PLGF; PlGF-2; SHGC-10760 placental growth factor
TCMBANKGE014217 GNRH1 GNRH; GRH; LHRH; LNRH gonadotropin releasing hormone 1
TCMBANKGE000747 GAPDH G3PD; GAPD; HEL-S-162eP glyceraldehyde-3-phosphate dehydrogenase
TCMBANKGE012048 HLA-B AS; B-4901; HLAB major histocompatibility complex, class I, B
TCMBANKGE000977 SMAD1 BSP-1; BSP1; JV4-1; JV41; MADH1; MADR1 SMAD family member 1
TCMBANKGE001096 TLR4 ARMD10; CD284; TLR-4; TOLL toll like receptor 4
TCMBANKGE001108 BMP2 BDA2; BMP2A; SSFSC bone morphogenetic protein 2
TCMBANKGE002355 HAMP HEPC; HFE2B; LEAP1; PLTR hepcidin antimicrobial peptide
TCMBANKGE001620 TMPRSS6 IRIDA; MT2 transmembrane serine protease 6
TCMBANKGE003719 BMP6 VGR; VGR1 bone morphogenetic protein 6
TCMBANKGE002089 TNMD BRICD4; CHM1L; TEM tenomodulin
TCMBANKGE000330 HMOX1 HMOX1D; HO-1; HSP32; bK286B10 heme oxygenase 1
TCMBANKGE013184 HP BP; HP2ALPHA2; HPA1S haptoglobin
TCMBANKGE002115 HLA-F CDA12; HLA-5.4; HLA-CDA12; HLAF major histocompatibility complex, class I, F
TCMBANKGE000389 MMP3 CHDS6; MMP-3; SL-1; STMY; STMY1; STR1 matrix metallopeptidase 3
TCMBANKGE009752 BTBD9 dJ322I12.1 BTB domain containing 9
TCMBANKGE000850 CYLD BRSS; CDMT; CYLD1; CYLDI; EAC; MFT; MFT1; SBS; TEM; USPL2 CYLD lysine 63 deubiquitinase
TCMBANKGE001401 PCSK7 LPC; PC7; PC8; SPC7 proprotein convertase subtilisin/kexin type 7

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇IICP备16009434号-1 | Dai SX Lab